Ads
related to: crispr
Search results
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 2 days agoWith a gene therapy for two illnesses out the door, and with sales slated to take off over the next few quarters, CRISPR Therapeutics (NASDAQ: CRSP) is...
Is CRISPR Therapeutics Stock a Buy? | The Motley Fool
The Motley Fool· 7 days agoCRISPR Therapeutics (CRSP -1.40%) is a star in the gene-editing therapy niche. The company made...
The Realities And Ethics Of Pig Organ Transplants In Humans : 1A
NPR· 13 hours agoWith CRISPR technology, scientists can edit pig genes to be more compatible with a human body, or at...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.3%
ETF DAILY NEWS· 5 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price dropped 0.3% during mid-day trading on Friday . The company traded as low as $54.64 and last traded at ...
ERS Genomics and IRBM sign CRISPR / Cas9 license agreement
BioPharma-Reporter· 4 days agoCRISPR licensing company ERS Genomics and drug discovery firm IRBM have entered into a non-exclusive...
BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
TipRanks via Yahoo Finance· 7 days agoLast week, Bluebird Bio (NASDAQ:BLUE) shares climbed while CRISPR Therapeutics (NASDAQ:CRSP) stock...
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Motley Fool via Yahoo Finance· 2 days agoLet's check out these two bull market buys to own for the long run. Image source: Getty Images. 1. ...
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool via Yahoo Finance· 2 days agoThe good news is that it didn't move lower on the news, even though the shares are still down 16%...
The 2030 Millionaire's Club: 3 Biotech Stocks to Buy Now
InvestorPlace· 22 hours agoWith the interest cuts coming up, it’s an ideal time to consider loading up on the top biotech...
New CRISPR screening method could reveal what drives brain diseases
Medical Xpress· 4 days agoThe method, outlined in a study published in Cell on May 20, 2024, provides a way to rapidly examine the brain cell types linked to key developmental genes at a scale never done before—helping ...